Reported May 6, 2026 · Ongoing
Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79…
Scope Health
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: SCOPE HEALTH · 79 Madison Avenue · New York, NY · 10016-7921
Is this the product you have?
Optase Dry Eye Intense Drops (Glycerin 0.2%)packaged in 0.33 fl ozSterileManufactured for Scope Health Inc79 Madison Ave8th FloorNew YorkNY 10016USANDC 72972-002-01
- Lot codes and dates
Lot#: 8T989T319T32Exp
- Date
30/04/262V132V142V15Exp. Date 30/06/263V35Exp. Date 31/08/263V363V37Exp. Date 30/09/265V455V469V12Exp. Date 31/03/271X571X701X84Exp. Date 31/05/27
Where it was sold
- Nationwide
Why it was recalled
Lack of Assurance of Sterility
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Scope Health recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.